MAGNIFUSE BONE GRAFT PRECLINICAL EVIDENCE Bone Grafting (Spine and Orthopaedic)
Magnifuse II DBM (provided allograft and recovered autograft):
The following are contraindications for the use of Magnifuse™ DBM Bone Graft and Magnifuse™ II Bone Graft:
This product may contain trace amounts of antibiotics (gentamicin), surfactant, and other solutions used in processing the bone tissue as well as the PGA mesh. Caution should be exercised if the patient is allergic to these antibiotics or chemicals.
For more details see Indications, Safety, and Warnings.
Data on file. Animal studies are not necessarily indicative of human clinical outcome.